Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uvealmelanoma: A clinicopathological study

Citation
G. Anastassiou et al., Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uvealmelanoma: A clinicopathological study, ONCOL-BASEL, 58(1), 2000, pp. 83-88
Citations number
30
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
ONCOLOGY
ISSN journal
00302414 → ACNP
Volume
58
Issue
1
Year of publication
2000
Pages
83 - 88
Database
ISI
SICI code
0030-2414(2000)58:1<83:EOTCAM>2.0.ZU;2-V
Abstract
To investigate the relationship between the expression of the cell adhesion molecules intercellular cell adhesion molecule-1 (ICAM-1), vascular cell a dhesion molecule-1 (VCAM-1) and neural cell adhesion molecule (NCAM) in uve al melanoma and the metastatic spread in the first 5 years after diagnosis, we performed a hospital-based case-control study with human tissue from 90 patients who underwent enucleation for primary uveal melanoma (iris melano ma excluded). Thirty-five patients developed metastasis within the first 5 years, and 55 patients lived metastasis-free for at least 5 years after enu cleation. The paraffin-embedded and formalin-fixed globes were studied by i mmunohistochemistry with monoclonal antibodies for ICAM-1, VCAM-1 and NCAM. A strong ICAM-1 positivity (more than 75% of the tumor cells stained posit ive) was detected in 73 tumors (81%). The expression of 75% or less ICAM-1 positive cells in tumors was strongly associated with the development of me tastases (odds ratio: 7.5, p = 0.001). Multiple logistic regression models showed that ICAM-1 is an independent risk factor for metastasis even after control for important prognostic markers like extraocular growth, ciliary b ody involvement, scleral infiltration and cell type. VCAM-1 was expressed i n 24 out of 88 tumors (27.3%) and NCAM only in 14 out of 87 tumors (16%). O nly spindle cells stained positive with anti-NCAM. NCAM and VCAM-1 expressi on was not related to metastasis. Our results show that the loss of ICAM-1 expression is associated with an increased risk of metastasis within the fi rst 5 years after diagnosis. Copyright (C) 2000 S. Karger AG. Basel.